| Description | Pozelimab (REGN3918), a fully human IgG4 monoclonal antibody, is designed to target and bind with high affinity to both C5 and its variants, effectively inhibiting complement-mediated hemolysis. It holds potential for research into complement-mediated diseases [1]. |
| molecular weight | N/A |
| CAS | 2096328-94-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |